Ask Ayurveda

To Buy 2017: Worst Stocks

Even the blue-chip Dow had its share of laggards. According to CNBC : : -7% Exxon Mobil : -7% Merck : -4% Verizon : -0.8%

Facing investigations into billing practices and rising labor costs, this medical services provider saw its value nearly halve by year-end. : -44% worst stocks to buy 2017

The utility company’s stock collapsed after it abandoned a massive nuclear power project in South Carolina, leading to state and federal investigations. : -45% Even the blue-chip Dow had its share of laggards

Once a high-growth favorite, the retailer faced fierce competition and repeatedly slashed its sales forecasts as consumer preferences shifted. : -46% : -45% Once a high-growth favorite, the retailer

The owner of Kay and Zales faced reputation issues following discrimination lawsuits and investigations into its financing practices.

Burdened by massive debt and weak natural gas prices, investors remained skeptical of the company's ability to balance its books. : -41%